Amrize jumps 11% on Q4 results, upbeat 2026 outlook, and new shareholder return plan

Amrize (AMRZ) is up 11.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to Amrize’s fourth-quarter and full-year 2025 results and its 2026 outlook, alongside a newly announced shareholder return framework. Investors may also be reacting to strong cash generation and a lower year-end leverage profile, which can support buybacks, dividends, and growth investment.

Details:

Amrize reported 2025 revenue of $11.8 billion (up 0.9%) and adjusted EBITDA of $3.0 billion, alongside operating cash flow of $2.2 billion and free cash flow of $1.5 billion.

The company proposed a shareholder return plan that includes a $1.0 billion share repurchase authorization plus a $0.44 per-share special one-time dividend and a $0.44 per-share annual ordinary dividend (subject to approvals/board discretion as described by the company).

Amrize issued 2026 guidance calling for revenue growth of 4% to 6% (to $12.29 billion–$12.52 billion) and adjusted EBITDA growth of 8% to 11% (to $3.25 billion–$3.34 billion).

Year-end net debt was about $3.347 billion and the net leverage ratio was 1.1x, down from 1.7x at the end of Q3 2025.

Sources:

Amrize Investor Relations

The Motley Fool

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$AMRZ Insider Trading Activity

$AMRZ insiders have traded $AMRZ stock on the open market 8 times in the past 6 months. Of those trades, 8 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $AMRZ stock by insiders over the last 6 months:

JAN PHILIPP JENISCH (Chairman & CEO) has made 2 purchases buying 110,000 shares for an estimated $5,803,600 and 0 sales.
ROALD BROUWER (Chief Technology Officer) has made 3 purchases buying 6,000 shares for an estimated $310,860 and 0 sales.
JAIME HILL (President, Building Materials) has made 2 purchases buying 4,500 shares for an estimated $227,532 and 0 sales.
NICHOLAS C GANGESTAD purchased 2,000 shares for an estimated $94,680

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$AMRZ Hedge Fund Activity

We have seen 264 institutional investors add shares of $AMRZ stock to their portfolio, and 172 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

HARRIS ASSOCIATES L P added 11,379,547 shares (+inf%) to their portfolio in Q4 2025, for an estimated $615,405,901
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 9,116,146 shares (+1674.2%) to their portfolio in Q4 2025, for an estimated $493,001,175
FMR LLC removed 7,341,821 shares (-59.4%) from their portfolio in Q4 2025, for an estimated $397,045,679
BLACKROCK, INC. added 5,560,320 shares (+64.4%) to their portfolio in Q4 2025, for an estimated $300,702,105
WELLINGTON MANAGEMENT GROUP LLP added 3,809,133 shares (+48.8%) to their portfolio in Q3 2025, for an estimated $184,857,224
NORGES BANK added 3,481,270 shares (+25.9%) to their portfolio in Q4 2025, for an estimated $188,267,081
FIRST PACIFIC ADVISORS, LP added 3,408,072 shares (+inf%) to their portfolio in Q4 2025, for an estimated $184,308,533

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$AMRZ Analyst Ratings

Wall Street analysts have issued reports on $AMRZ in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Citigroup issued a "Buy" rating on 01/08/2026
Stephens & Co. issued a "Overweight" rating on 11/14/2025
Wells Fargo issued a "Overweight" rating on 10/30/2025
Oppenheimer issued a "Outperform" rating on 09/09/2025
JP Morgan issued a "Overweight" rating on 08/26/2025

To track analyst ratings and price targets for $AMRZ, check out Quiver Quantitative's $AMRZ forecast page.

$AMRZ Price Targets

Multiple analysts have issued price targets for $AMRZ recently. We have seen 8 analysts offer price targets for $AMRZ in the last 6 months, with a median target of $60.0.

Here are some recent targets:

Timna Tanners from Wells Fargo set a target price of $59.0 on 01/29/2026
Bryan Blair from Oppenheimer set a target price of $64.0 on 01/15/2026
Marcus Cole from UBS set a target price of $57.0 on 01/08/2026
Anthony Pettinari from Citigroup set a target price of $67.0 on 01/08/2026
Anthony Codling from RBC Capital set a target price of $60.0 on 12/08/2025
Trey Grooms from Stephens & Co. set a target price of $60.0 on 11/14/2025
Adrian Huerta from JP Morgan set a target price of $60.0 on 08/26/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.